Impax Asset Management Group PLC Jazz Pharmaceuticals PLC Transaction History

Impax Asset Management Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$122.5 - $147.16 $36,750 - $44,148	300 Added 17.5%	2,014 $249,000
Q1 2023 May 10, 2023	BUY	$133.98 - $160.47 $25,724 - $30,810	192 Added 12.61%	1,714 $250,000
Q4 2022 Feb 09, 2023	SELL	$129.72 - $159.85 $96,381 - $118,768	-743 Reduced 32.8%	1,522 $242,000
Q3 2022 Nov 08, 2022	BUY	$126.59 - $161.18 $48,357 - $61,570	382 Added 20.29%	2,265 $302,000
Q2 2022 Aug 11, 2022	SELL	$141.59 - $168.66 $3,114 - $3,710	-22 Reduced 1.15%	1,883 $294,000
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $13,352 - $16,552	-103 Reduced 5.13%	1,905 $297,000
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $240,698 - $292,505	2,008 New	2,008 $255,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.